Press Releases
Quaker Chemical Announces Fourth Quarter and Full Year 2017 Results
The Company had a net loss of
Mr. Barry continued, "Looking forward to 2018, we currently expect to close our combination with Houghton during the first half of 2018. We are still awaiting regulatory approvals in the U.S. and
Fourth Quarter of 2017 Summary
Net sales in the fourth quarter of 2017 were
Gross profit in the fourth quarter of 2017 increased
SG&A increased
The Company substantially completed its 2015 global restructuring program during 2016 and recognized a restructuring credit of
In the fourth quarter of 2017, the Company incurred
Operating income in the fourth quarter of 2017 was
Other income (expense), net, increased
Interest expense increased
The Company's effective tax rates for the fourth quarters of 2017 and 2016 were 163.0% and 17.3%, respectively. The Company's inflated fourth quarter of 2017 effective tax rate was largely driven by
Equity in net income of associated companies ("equity income") increased
The Company's net income attributable to noncontrolling interest decreased
In addition to the foreign currency transaction gains realized in other income noted above, the impacts from foreign currency translation also positively impacted the Company's fourth quarter of 2017 results by approximately 2%, or
Full Year 2017 Summary
Net sales in 2017 were
Gross profit in 2017 increased
SG&A increased
Related to the 2015 global restructuring program, the Company recognized a restructuring credit of
During 2017, the Company incurred
Operating income in 2017 was
The Company had other expense of
Interest expense increased
The Company's effective tax rates for 2017 and 2016 were 68.7% and 27.6%, respectively. The primary drivers of the increase in the Company's effective tax rate in 2017 were the impact of U.S. Tax Reform and the impact of certain non-deductible Houghton combination-related expenses, partially offset by the favorable impact of an accounting standard that was adopted in the current year regarding the tax impact of certain share-based compensation. The Company estimates that its 2017 effective tax rate would have been approximately 27%, without the impact of U.S. Tax Reform and certain non-deductible Houghton combination-related expenses.
Equity income increased
The Company's net income attributable to noncontrolling interest increased
Foreign currency translation negatively impacted the Company's 2017 results by less than 1%, or
Balance Sheet and Cash Flow Items
The Company's net operating cash flow of
U.S. Tax Reform
On
Houghton Combination
On
Non-GAAP Measures
Included in this public release are two non-GAAP (unaudited) financial measures: non-GAAP earnings per diluted share and adjusted EBITDA. The Company believes these non-GAAP financial measures provide meaningful supplemental information as they enhance a reader's understanding of the financial performance of the Company, are more indicative of future operating performance of the Company, and facilitate a better comparison among fiscal periods, as the non-GAAP financial measures exclude items that are not considered core to the Company's operations. Non-GAAP results are presented for supplemental informational purposes only and should not be considered a substitute for the financial information presented in accordance with GAAP.
The following tables reconcile non-GAAP earnings per diluted share (unaudited) and adjusted EBITDA (unaudited) to their most directly comparable GAAP financial measures:
Three Months Ended December 31, |
Twelve Months Ended December 31, |
||||||
2017 |
2016 |
2017 |
2016 |
||||
GAAP (loss) earnings per diluted share attributable |
$ (0.73) |
$ 1.31 |
$ 1.52 |
$ 4.63 |
|||
Equity income in a captive insurance company per |
(0.08) |
(0.06) |
(0.19) |
(0.13) |
|||
Restructuring credit per diluted share |
— |
(0.02) |
— |
(0.02) |
|||
Houghton combination-related expenses per diluted |
0.43 |
0.03 |
1.90 |
0.11 |
|||
U.S. Tax Reform charges per diluted share (b) |
1.67 |
— |
1.67 |
— |
|||
U.S. pension plan settlement charge per diluted share |
— |
— |
0.09 |
— |
|||
Cost streamlining initiative per diluted share |
— |
— |
0.01 |
— |
|||
Loss on disposal of held-for-sale asset per diluted share |
0.01 |
— |
0.01 |
— |
|||
Insurance insolvency recovery per diluted share |
(0.03) |
— |
(0.03) |
— |
|||
Currency conversion impacts of the Venezuelan |
0.00 |
— |
0.03 |
0.01 |
|||
Non-GAAP earnings per diluted share |
$ 1.27 |
$ 1.26 |
$ 5.01 |
$ 4.60 |
|||
Three Months Ended December 31, |
Twelve Months Ended December 31, |
||||||
2017 |
2016 |
2017 |
2016 |
||||
Net (loss) income attributable to Quaker Chemical |
$ (9,762) |
$ 17,434 |
$ 20,278 |
$ 61,403 |
|||
Depreciation and amortization |
5,012 |
4,778 |
19,966 |
19,566 |
|||
Interest expense (a) |
1,664 |
663 |
3,892 |
2,889 |
|||
Taxes on income before equity in net income of |
27,424 |
3,562 |
41,653 |
23,226 |
|||
Equity income in a captive insurance company |
(1,120) |
(736) |
(2,547) |
(1,688) |
|||
Restructuring credit |
— |
(439) |
— |
(439) |
|||
Houghton combination-related expenses (a) |
6,850 |
374 |
29,938 |
1,531 |
|||
U.S. pension plan settlement charge |
— |
— |
1,860 |
— |
|||
Cost streamlining initiative |
— |
— |
286 |
— |
|||
Loss on disposal of held-for-sale asset |
125 |
— |
125 |
— |
|||
Insurance insolvency recovery |
(600) |
— |
(600) |
— |
|||
Currency conversion impacts of the Venezuelan |
13 |
— |
388 |
88 |
|||
Adjusted EBITDA |
$ 29,606 |
$ 25,636 |
$ 115,239 |
$ 106,576 |
|||
Adjusted EBITDA margin (%) |
14.0% |
13.4% |
14.1% |
14.3% |
(a) |
During September 2017, the Company began to incur interest costs to maintain the capital commitment related to the pending Combination. These interest costs are included within the caption Houghton combination-related expenses in the reconciliation of GAAP earnings per diluted share attributable to Quaker Chemical Corporation common shareholders to Non-GAAP earnings per diluted share. These interest costs are included within the caption Interest expense in the reconciliation of Net income attributable to Quaker Chemical Corporation to Adjusted EBITDA. |
(b) |
U.S. Tax Reform charges of $22.2 million are included within Taxes on income before equity in net income of associated companies in the reconciliation of Net income attributable to Quaker Chemical Corporation to Adjusted EBITDA. |
Forward-Looking Statements
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those projected in such statements. A major risk is that demand for the Company's products and services is largely derived from the demand for its customers' products, which subjects the Company to uncertainties related to downturns in a customer's business and unanticipated customer production shutdowns. Other major risks and uncertainties include, but are not limited to, significant increases in raw material costs, customer financial stability, worldwide economic and political conditions, foreign currency fluctuations, significant changes in applicable tax rates and regulations, future terrorist attacks and other acts of violence. Other factors, including those related to the previously announced pending Houghton combination, could also adversely affect us. For more information regarding these risks and uncertainties as well as certain additional risks that we face, you should refer to the Risk Factors detailed in Item 1A of our Form 10-K for the year ended
Conference Call
As previously announced,
About Quaker
Quaker Chemical Corporation |
|||||||
Consolidated Statements of Income |
|||||||
(Dollars in thousands, except share and per share data) |
|||||||
Three Months Ended December 31, |
Twelve Months Ended December 31, |
||||||
2017 |
2016 |
2017 |
2016 |
||||
Net sales |
$ 211,072 |
$ 191,245 |
$ 820,082 |
$ 746,665 |
|||
Cost of goods sold |
137,075 |
121,414 |
528,587 |
466,555 |
|||
Gross profit |
73,997 |
69,831 |
291,495 |
280,110 |
|||
% |
35.1% |
36.5% |
35.5% |
37.5% |
|||
Selling, general and administrative expenses |
50,073 |
48,945 |
198,813 |
193,665 |
|||
Restructuring and related activities |
- |
(439) |
- |
(439) |
|||
Combination-related expenses |
6,850 |
374 |
29,938 |
1,531 |
|||
Operating income |
17,074 |
20,951 |
62,744 |
85,353 |
|||
% |
8.1% |
11.0% |
7.7% |
11.4% |
|||
Other income (expense), net |
709 |
(247) |
(718) |
(492) |
|||
Interest expense |
(1,664) |
(663) |
(3,892) |
(2,889) |
|||
Interest income |
709 |
593 |
2,534 |
2,037 |
|||
Income before taxes and equity in net income of associated companies |
16,828 |
20,634 |
60,668 |
84,009 |
|||
Taxes on income before equity in net income of associated companies |
27,424 |
3,562 |
41,653 |
23,226 |
|||
(Loss) income before equity in net income of associated companies |
(10,596) |
17,072 |
19,015 |
60,783 |
|||
Equity in net income of associated companies |
1,237 |
867 |
3,285 |
2,256 |
|||
Net (loss) income |
(9,359) |
17,939 |
22,300 |
63,039 |
|||
Less: Net income attributable to noncontrolling interest |
403 |
505 |
2,022 |
1,636 |
|||
Net (loss) income attributable to Quaker Chemical Corporation |
$ (9,762) |
$ 17,434 |
$ 20,278 |
$ 61,403 |
|||
% |
-4.6% |
9.1% |
2.5% |
8.2% |
|||
Share and per share data: |
|||||||
Basic weighted average common shares outstanding |
13,230,441 |
13,157,411 |
13,204,872 |
13,136,138 |
|||
Diluted weighted average common shares outstanding |
13,267,652 |
13,198,611 |
13,245,946 |
13,160,469 |
|||
Net (loss) income attributable to Quaker Chemical Corporation |
$ (0.73) |
$ 1.31 |
$ 1.53 |
$ 4.64 |
|||
Net (loss) income attributable to Quaker Chemical Corporation |
$ (0.73) |
$ 1.31 |
$ 1.52 |
$ 4.63 |
Quaker Chemical Corporation |
|||
Consolidated Balance Sheets |
|||
(Dollars in thousands, except par value and share amounts) |
|||
December 31, |
|||
2017 |
2016 |
||
ASSETS |
|||
Current assets |
|||
Cash and cash equivalents |
$ 89,879 |
$ 88,818 |
|
Accounts receivable, net |
208,358 |
195,225 |
|
Inventories, net |
87,221 |
77,082 |
|
Prepaid expenses and other current assets |
21,128 |
15,343 |
|
Total current assets |
406,586 |
376,468 |
|
Property, plant and equipment, net |
86,704 |
85,734 |
|
Goodwill |
86,034 |
80,804 |
|
Other intangible assets, net |
71,603 |
73,071 |
|
Investments in associated companies |
25,690 |
22,817 |
|
Non-current deferred tax assets |
15,460 |
24,382 |
|
Other assets |
30,049 |
28,752 |
|
Total assets |
$ 722,126 |
$ 692,028 |
|
LIABILITIES AND EQUITY |
|||
Current liabilities |
|||
Short-term borrowings and current portion of long-term debt |
$ 5,736 |
$ 707 |
|
Accounts payable |
93,008 |
77,583 |
|
Dividends payable |
4,724 |
4,581 |
|
Accrued compensation |
22,846 |
19,356 |
|
Accrued restructuring |
- |
670 |
|
Accrued pension and postretirement benefits |
1,108 |
1,086 |
|
Other current liabilities |
27,321 |
23,428 |
|
Total current liabilities |
154,743 |
127,411 |
|
Long-term debt |
61,068 |
65,769 |
|
Non-current deferred tax liabilities |
9,653 |
12,008 |
|
Non-current accrued pension and postretirement benefits |
35,548 |
38,348 |
|
Other non-current liabilities |
51,496 |
35,886 |
|
Total liabilities |
312,508 |
279,422 |
|
Equity |
|||
Common stock, $1 par value; authorized 30,000,000 shares; issued and |
13,308 |
13,278 |
|
Capital in excess of par value |
93,528 |
112,475 |
|
Retained earnings |
365,936 |
364,414 |
|
Accumulated other comprehensive loss |
(65,100) |
(87,407) |
|
Total Quaker shareholders' equity |
407,672 |
402,760 |
|
Noncontrolling interest |
1,946 |
9,846 |
|
Total equity |
409,618 |
412,606 |
|
Total liabilities and equity |
$ 722,126 |
$ 692,028 |
Quaker Chemical Corporation |
|||
Consolidated Statements of Cash Flows |
|||
(Dollars in thousands) |
|||
Twelve Months Ended December 31, |
|||
2017 |
2016 |
||
Cash flows from operating activities |
|||
Net income |
$ 22,300 |
$ 63,039 |
|
Adjustments to reconcile net income to net cash provided by operating activities: |
|||
Depreciation |
12,598 |
12,557 |
|
Amortization |
7,368 |
7,009 |
|
Equity in undistributed earnings of associated companies, net of dividends |
(2,895) |
(1,969) |
|
Deferred income taxes |
3,754 |
5,488 |
|
Uncertain tax positions (non-deferred portion) |
(817) |
(3,206) |
|
Non-current income tax payable |
15,825 |
- |
|
Deferred compensation and other, net |
1,074 |
(424) |
|
Share-based compensation |
4,190 |
6,349 |
|
Restructuring and related activities |
- |
(439) |
|
Loss (gain) on disposal of property, plant, equipment and other assets |
79 |
(18) |
|
Insurance settlement realized |
(762) |
(1,023) |
|
Combination-related expenses, net of payments |
4,952 |
503 |
|
Pension and other postretirement benefits |
(123) |
(3,420) |
|
(Decrease) increase in cash from changes in current assets and current |
|||
Accounts receivable |
(1,941) |
(11,705) |
|
Inventories |
(6,135) |
(1,870) |
|
Prepaid expenses and other current assets |
(2,932) |
(703) |
|
Accounts payable and accrued liabilities |
12,381 |
14,063 |
|
Restructuring liabilities |
(675) |
(5,252) |
|
Estimated taxes on income |
(3,479) |
(5,226) |
|
Net cash provided by operating activities |
64,762 |
73,753 |
|
Cash flows from investing activities |
|||
Investments in property, plant and equipment |
(10,872) |
(9,954) |
|
Payments related to acquisitions, net of cash acquired |
(5,363) |
(15,024) |
|
Proceeds from disposition of assets |
1,577 |
186 |
|
Insurance settlement interest earned |
50 |
32 |
|
Change in restricted cash, net |
712 |
991 |
|
Net cash used in investing activities |
(13,896) |
(23,769) |
|
Cash flows from financing activities |
|||
Repayments of long-term debt |
(2,853) |
(14,513) |
|
Dividends paid |
(18,613) |
(17,625) |
|
Stock options exercised, other |
(1,956) |
(811) |
|
Payments for repurchase of common stock |
- |
(5,859) |
|
Excess tax benefit related to stock option exercises |
- |
678 |
|
Purchase of noncontrolling interest in affiliates, net |
(31,787) |
- |
|
Net cash used in financing activities |
(55,209) |
(38,130) |
|
Effect of exchange rate changes on cash |
5,404 |
(4,089) |
|
Net increase in cash and cash equivalents |
1,061 |
7,765 |
|
Cash and cash equivalents at the beginning of the period |
88,818 |
81,053 |
|
Cash and cash equivalents at the end of the period |
$ 89,879 |
$ 88,818 |
|
View original content with multimedia:http://www.prnewswire.com/news-releases/quaker-chemical-announces-fourth-quarter-and-full-year-2017-results-300606132.html
SOURCE
Mary Dean Hall, Vice President, Chief Financial Officer and Treasurer, Hallm@quakerchem.com, T. 610.832.4160